Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 3/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.47 |
| ▸ | PTGES | O14684 | 4/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 3/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8436475 | 0.84 | ALOX5 (0.43) | ALOX5PTGESPPARGCNR1 | |
| SCHEMBL9301856 | 0.80 | APEX1 (0.53) | APEX1ALOX5PTGESPPARGCNR1 | |
| SCHEMBL39941 | 0.80 | APEX1 (0.53) | APEX1ALOX5PTGESPPARGCNR1 | |
| SCHEMBL2489081 | 0.80 | APEX1 (0.53) | APEX1ALOX5PTGESPPARGCNR1 | |
| SCHEMBL2490383 | 0.79 | ALOX5 (0.54) | APEX1ALOX5PTGESPPARGCNR1 | |
| SCHEMBL5319431 | 0.79 | MEN1 (0.53) | APEX1ALOX5PTGESPPARGEPHX2 | |
| SCHEMBL7824349 | 0.75 | PTGES (0.55) | APEX1ALOX5PTGESPPARG | |
| SCHEMBL7824347 | 0.75 | PTGES (0.55) | APEX1ALOX5PTGESPPARG | |
| SCHEMBL38662595 | 0.75 | APEX1 (0.48) | APEX1ALOX5PTGESPPARGEPHX2 | |
| SCHEMBL6367852 | 0.74 | ALOX5 (0.58) | APEX1ALOX5PTGESPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040219115-A1 | Cosmetic composition | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-11-04 | — | — | US | claimed |
| WO-2004066973-A1 | SKIN LIGHTENING COMPOSITION | UNILEVER PLC (GB) | 2004-08-12 | — | — | WO | claimed |
| US-20210106507-A1 | METHOD OF INCREASING DURABILITY OF OIL-IN-WATER EMULSION MAKEUP | SHISEIDO COMPANY, LTD. (JP) | 2021-04-15 | — | — | US | disclosed |
| US-10894875-B2 | Films and unit dose articles comprising aversive UV-protective agents, and uses and methods related thereto | THE PROCTER & GAMBLE COMPANY (US) | 2021-01-19 | — | — | US | disclosed |
| EP-2591082-B1 | COMPOSITIONS COMPRISING OPTICAL BENEFIT AGENTS | UNILEVER PLC (GB) | 2020-11-18 | — | — | EP | disclosed |
| EP-3498812-B1 | FILMS AND UNIT DOSE ARTICLES COMPRISING AVERSIVE UV-PROTECTIVE AGENTS, AND USES AND METHODS RELATED THERETO | PROCTER & GAMBLE (US) | 2020-06-17 | — | — | EP | disclosed |
| US-20200069541-A1 | OIL-IN-WATER TYPE EMULSION COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2020-03-05 | — | — | US | disclosed |
| EP-3613409-A1 | METHOD FOR PRODUCING ULTRAVIOLET PROTECTION COATING FILM | Kao Corporation (JP) | 2020-02-26 | — | — | EP | disclosed |
| US-20190262252-A1 | OIL BASED COMPOSITION AND OIL BASED COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2019-08-29 | — | — | US | disclosed |
| EP-3530264-A1 | OIL-IN-WATER-TYPE EMULSION COMPOSITION | Shiseido Company, Ltd. (JP) | 2019-08-28 | — | — | EP | disclosed |
| US-20190185637-A1 | FILMS AND UNIT DOSE ARTICLES COMPRISING AVERSIVE UV-PROTECTIVE AGENTS, AND USES AND METHODS RELATED THERETO | THE PROCTER & GAMBLE COMPANY | 2019-06-20 | — | — | US | disclosed |
| US-5919751-A | ADDITIONAL BENEFIT, OTHER THAN MERELY SOFTENING OR PERFUMING THE FABRIC. WATER INSOLUBLE OIL CATIONIC QUATERNARY AMMONIUM COMPOUND, SULPHONATE, PHOSPHATE OR COMPOUND HAVING A MOLECULAR WEIGHT GREATER THAN 1000 | LEVER BROTHERS COMPANY (US) | 1999-07-06 | — | — | US | disclosed |
| EP-0912673-A1 | FABRIC CONDITIONING COMPOSITION | UNILEVER PLC (GB) | 1999-05-06 | — | — | EP | disclosed |
| EP-0570230-B1 | External preparation for skin | SHISEIDO CO LTD (JP) | 1998-09-30 | — | — | EP | disclosed |
| EP-0846461-A1 | OIL-IN-WATER EMULSION COMPOSITION AND OIL-IN-WATER EMULSIFIER | SHISEIDO COMPANY LIMITED (JP) | 1998-06-10 | — | — | EP | disclosed |
| WO-1997044424-A1 | FABRIC CONDITIONING COMPOSITION | UNILEVER PLC (GB) | 1997-11-27 | — | — | WO | disclosed |
| US-5580549-A | BLEACHING; 2-HYDROXYBENZOIC ACID COMPOUND | SHISEIDO CO., LTD. (JP) | 1996-12-03 | — | — | US | disclosed |
| EP-0570230-A1 | External preparation for skin | SHISEIDO COMPANY LIMITED (JP) | 1993-11-18 | — | — | EP | disclosed |
| US-5247121-A | Cosmetics | L'OREAL (FR) | 1993-09-21 | — | — | US | disclosed |
| US-5112601-A | Cosmetics | L'OREAL (FR) | 1992-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210106507-A1 | METHOD OF INCREASING DURABILITY OF OIL-IN-WATER EMULSION MAKEUP | CUTA, LIPA, POLI | APEX1 1061/4885ALOX5 70/4885PTGES 316/4885 |
| US-20200069541-A1 | OIL-IN-WATER TYPE EMULSION COMPOSITION | LIPA, CUTA, FAM83A | APEX1 4021/4885ALOX5 74/4885PTGES 493/4885 |
| US-10894875-B2 | Films and unit dose articles comprising aversive UV-protective agents, and uses and methods related thereto | UBXN1, UBXN4, UBQLN1 | APEX1 619/4885ALOX5 1543/4885PTGES 3207/4885 |
| US-20190185637-A1 | FILMS AND UNIT DOSE ARTICLES COMPRISING AVERSIVE UV-PROTECTIVE AGENTS, AND USES AND METHODS RELATED THERETO | UBXN1, UBXN4, UBQLN1 | APEX1 619/4885ALOX5 1543/4885PTGES 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.